GlassScriptPhysician profile
Marie L Malinchak
NPI 1871577015
$10,272.84
in general payments reported to CMS, 2019-2025
60 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,558 · 2020: $193 · 2021: $985 · 2022: $1,765 · 2023: $2,105 · 2024: $2,061 · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,772.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,212.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,063.96 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $770.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $749.54 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $664.60 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $646.00 | 2022-2025 | Rexulti, Abilify Maintena |
| Amgen INC. | $491.30 | 2019-2025 | Otezla, Repatha, Prolia |
| Abbott Laboratories | $351.73 | 2019-2025 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $344.10 | 2019-2025 | Trintellix |
| Glaxosmithkline, LLC. | $333.80 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $316.53 | 2019-2025 | Xifaxan, Relistor |
| Janssen Pharmaceuticals, INC | $293.75 | 2019-2025 | Spravato |
| Dexcom, INC. | $289.40 | 2023-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $239.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $230.10 | 2019-2025 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.72 | 2019-2023 | Jardiance |
| Bausch Health US, LLC | $117.76 | 2019-2022 | |
| Amarin Pharma, INC. | $117.00 | 2019-2022 | |
| Lundbeck LLC | $114.91 | 2024-2025 | Rexulti, Vyepti |
| Teva Pharmaceuticals USA, INC. | $114.81 | 2019-2024 | Ajovy |
| Bayer Healthcare Pharmaceuticals INC. | $113.48 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $101.80 | 2019-2025 | Capvaxive, Vaxneuvance |
| Exact Sciences Corporation | $91.90 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $87.28 | 2019-2024 | Veozah, Myrbetriq |
| Biohaven Pharmaceuticals, INC. | $86.77 | 2021 | |
| Inspire Medical Systems, INC. | $77.77 | 2024-2025 | Inspire |
| Sanofi Pasteur INC. | $77.73 | 2023 | |
| Xeris Pharmaceuticals, INC. | $69.73 | 2023-2024 | Gvoke Hypopen |
| Mylan Specialty L.P. | $63.24 | 2024 | Yupelri |
| Esperion Therapeutics, INC. | $58.46 | 2025 | Nexletol |
| Corium, LLC | $44.34 | 2022-2024 | Azstarys |
| Idorsia Pharmaceuticals US INC | $43.43 | 2023-2024 | Quviviq |
| Allergan, INC. | $41.93 | 2019-2020 | |
| Acella Pharmaceuticals, LLC | $40.74 | 2025 | NP Thyroid 60 |
| Supernus Pharmaceuticals, INC. | $38.87 | 2021-2023 | Qelbree |
| Kowa Pharmaceuticals America, INC. | $38.32 | 2022 | |
| Eisai INC. | $37.20 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $36.78 | 2019 | |
| Tandem Diabetes Care, INC. | $36.39 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Avanir Pharmaceuticals, INC. | $36.20 | 2019-2022 | |
| Itamar Medical INC | $35.36 | 2025 | Watchpatone |
| Aytu Biopharma, INC. | $32.42 | 2019 | |
| Shire North American Group INC | $31.36 | 2019 | |
| Amneal Pharmaceuticals LLC | $28.94 | 2019 | |
| Mannkind Corporation | $28.61 | 2019 | |
| Currax Pharmaceuticals LLC | $27.96 | 2021-2023 | Contrave, Onzetra Xsail |
| Sumitomo Pharma America, INC. | $24.90 | 2025 | Gemtesa |
| Beta Bionics, INC. | $22.18 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Medtronic, INC. | $22.12 | 2025 | Synchromedii |
| Shield Therapeutics INC | $21.58 | 2023 | Accrufer |
| Antares Pharma, INC. | $20.36 | 2022 | |
| Genentech USA, INC. | $17.86 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.77 | 2021 | |
| Axsome Therapeutics, INC. | $16.36 | 2025 | Auvelity |
| Orapharma, A Division of Bausch Health US, LLC | $15.77 | 2023 | Ossix Plus, Arestin |
| E.R. Squibb & Sons, L.L.C. | $15.67 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.00 | 2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $14.74 | 2025 | Jornay Pm |
| Therapeuticsmd, INC. | $13.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Malinchak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.